Hem › Njurcancer (renalcelskarcinom) › Vermont
Kliniska studier för Njurcancer (renalcelskarcinom) i Vermont
3 studier för Njurcancer (renalcelskarcinom) söker deltagare vid platser i Vermont.
Officiell studietext (engelska)
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
- Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 18 sep. 2026 · NCT05327686Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
- Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 2 sep. 2026 · NCT06661720Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
- Norris Cotton Cancer Center-North, Saint Johnsbury
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 9 sep. 2025 · NCT04510597Från ClinicalTrials.gov, data hämtad 7 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.